First Candidate Molecule!


We are pleased to announce a partnership with Salk Institute For Biological Studies for funding development of a candidate molecule called J147. J147 is a molecule developed at Salk to treat Alzheimer’s and has shown encouraging results in the animal model. We recognized that it works in ways which are also relevant for ALS, and are currently preparing to commence fundraising to get the first experiments done in the ALS animal model. We are hopeful for similar results as in the Alzheimer’s model.

Leave a Reply

Your email address will not be published. Required fields are marked *